Universal Ibogaine Inc.

VANCOUVER, A1 · Founded 2018 · CIK 0001774925 · Biotech · Public

Ibogaine-based addiction treatment protocols and therapeutic modalities

universalibogaine.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$135K
3 Form D · Nov 2020
71 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$11,253
Private capital raisedForm D · SEC$75,920
Private capital raisedForm D · SEC$48,188
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1214Matrubials, Inc.——
1215MADRIGAL PHARMACEUTICALS, INC.—$35M
1216OS Therapies Inc—$30M
1217Universal Ibogaine Inc.—$135K
1218Willowcroft Pharm Inc—$5.0M
1219Valanbio Therapeutics Inc—$121K
1220IMMUNOQ THERAPEUTICS INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • ALBERTO AGULLODirector · Executive Officer
  • IAN CAMPBELLDirector
  • PATRICK KROUPADirector
  • SHAYNE NYQUVESTDirector · Executive Officer
  • ROBERT TURNERDirector
  • JEREMY WEATEDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.